5-27 | Drug resistant tuberculosis (DR-TB) is on the rise in Southern Africa, fueled on the one hand by high HIV prevalence, and on the other by its highly contagious nature. The disease reaches deep into rural Zimbabwe where MSF runs a DR-TB project.
5-19 | Phumeza TISILE, co-author of the DR-TB Manifesto* and XDR-TB survivor, delivers urgent plea to World Health Assembly delegates on behalf of 50,000 supporters worldwide On the eve of the World Health Assembly adopting an ambitious 20-year global plan to address tuberculosis (TB) and drug-resistant TB (DR-TB), MSF urges governments to focus intensely on improving DR-TB testing and care over the next 12 months.
3-24 | 24th March is the World Tuberculosis (TB) Day. A new briefing paper by Médecins Sans Frontières (MSF) outlines why the alarming spread of deadly strains of drug-resistant tuberculosis (DR-TB) is one of the biggest global health threats we face today. It calls on governments, pharmaceutical companies and researchers to mobilise urgently to save more lives and find new treatments to stem the virulent disease. Every year, around eight million people worldwide fall ill with tuberculosis (TB) and 1.3 million people die from the infectious airborne disease.
1-6 | Visit “See What We See” multimedia website The fight against HIV/AIDS has been hailed as one of the most successful public health projects in human history, but teams from Médecins Sans Frontières (MSF) see the revolution as unfulfilled for millions of people excluded from treatment.
8-19 | More steps need to be taken to secure access to one-pill-once-a-day HIV treatment The recent invalidation by China’s State Intellectual Property Office (SIPO) of one of the patents on tenofovir disoproxil fumarate (TDF), an essential medicine to treat HIV and hepatitis B, is a welcome step to reduce barriers that prevent access to affordable generic versions in China, according to Médecins Sans Frontières (MSF). “We are pleased that SIPO has invalidated a pat